Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II. Evaluation in a variety of clinical conditions.

Abstract

Plasmas from patients with a wide variety of thrombotic and presumed prethrombotic conditions were examined for high molecular weight crosslinked fibrin degradation products (known as X-oligomers) using a two-site enzyme-linked immunospecific assay (ELISA). This assay employed a catcher-tag principle using two monoclonal antibodies (mabs) directed towards… (More)

Topics

Cite this paper

@article{Gaffney1988MonoclonalAT, title={Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II. Evaluation in a variety of clinical conditions.}, author={Patrick J Gaffney and Lilo Creighton and M S Callus and Robin Thorpe}, journal={British journal of haematology}, year={1988}, volume={68 1}, pages={91-6} }